Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Down 16.7% in December

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the recipient of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 4,500 shares, a drop of 16.7% from the December 15th total of 5,400 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Laboratorios Farmaceuticos Rovi Price Performance

OTCMKTS:LABFF remained flat at C$65.86 during midday trading on Friday. The stock’s 50 day moving average price is C$71.31 and its 200 day moving average price is C$83.91. Laboratorios Farmaceuticos Rovi has a twelve month low of C$65.86 and a twelve month high of C$65.86.

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.